Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Transcutaneous Tibial Nerve Stimulation for Spinal Cord Injury Neurogenic Bladder

NCT: NCT04350359 · RECRUITING

NCT IDNCT04350359
StatusRECRUITING
Start Date2020-06-08
Completion2026-07-01

Brief Summary

The purpose of this study is to determine if electric stimulation to the leg, called transcutaneous tibial nerve stimulation (TTNS), can improve bladder outcomes in acute spinal cord injury.

Frequently Asked Questions

What is Transcutaneous Tibial Nerve Stimulation for Spinal Cord Injury Neurogenic Bladder?

Transcutaneous Tibial Nerve Stimulation for Spinal Cord Injury Neurogenic Bladder is a clinical trial registered under NCT04350359. Current status: RECRUITING.

What is the status of NCT04350359?

The current status of NCT04350359 (Transcutaneous Tibial Nerve Stimulation for Spinal Cord Injury Neurogenic Bladder) is: RECRUITING.

When did Transcutaneous Tibial Nerve Stimulation for Spinal Cord Injury Neurogenic Bladder start?

Transcutaneous Tibial Nerve Stimulation for Spinal Cord Injury Neurogenic Bladder started on 2020-06-08.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑